ELISE RIPPELMEYER: Open Payments
NPI 1407332406 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 15 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| W. L. Gore & Associates, Inc. | 1 | $94 |
| Eisai Inc. | 2 | $89 |
| TG Therapeutics, Inc. | 3 | $89 |
| Neurelis, Inc. | 1 | $28 |
| UCB, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Biogen, Inc. | 1 | $18 |
Products named: GORE CARDIOFORM Septal Occluder, Leqembi, BRIUMVI, VALTOCO, Zilbrysq, INGREZZA, Xeomin, Symbravo.
Industry payments across AR — which companies pay providers there.
